Results 141 to 150 of about 4,191,146 (301)

High dynamic range vector soliton mode-locking via nonlinear Sagnac gating

APL Photonics
Ultrafast fiber lasers enable vector soliton generation with richer dynamics than scalar solitons, offering enhanced flexibility for high-capacity communications and optical storage.
Kun Chen, Tao Cao, Xinyi Yan, Jinlong Zheng, Zhou Li, Qi Xu, Leyan Yang, Jing Li, Mingtao Peng, Yuxin Leng, Jiahui Peng   +10 more
doaj   +1 more source

Latest Advances of LLC Converters in High Current, Fast Dynamic Response, and Wide Voltage Range Applications

, 2017
Yang Chen
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

High-Dynamic-Range Tone Mapping in Intelligent Automotive Systems. [PDF]

Sensors (Basel), 2023
Shopovska I, Stojkovic A, Aelterman J, Van Hamme D, Philips W.   +4 more
europepmc   +1 more source

High dynamic range image processing for non-destructive-testing

, 2011
Bidisha Ghosh, Vikram Pakrashi, Franck Schoefs   +2 more
openalex   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

An 8-Channel Bidirectional Neurostimulator IC with a Highly-Linear High-Dynamic-Range ADC-Direct Architecture for Simultaneous Recording and Stimulation

, 2021
Tania Moeinfard
openalex   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

A 316MP, 120FPS, High Dynamic Range CMOS Image Sensor for Next Generation Immersive Displays. [PDF]

Sensors (Basel), 2023
Agarwal A, Hansrani J, Bagwell S, Rytov O, Shah V, Ong KL, Blerkom DV, Bergey J, Kumar N, Lu T, DaSilva D, Graae M, Dibble D.   +12 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source